GUIDANCE DOCUMENT
Dental Composite Resin Devices - Premarket Notification (510(k)) Submissions Draft Guidance for Industry and Food and Drug Administration Staff July 2024
Not for implementation. Contains non-binding recommendations.
- Docket Number:
- FDA-2024-D-2511
- Issued by:
-
Guidance Issuing OfficeCenter for Devices and Radiological Health
This draft guidance document provides the FDA’s recommendations on device description, non-clinical performance testing, clinical performance testing and labeling to support premarket submissions for dental composite resin devices. The recommendations reflect current review practices and are intended to promote consistency and facilitate efficient review of dental composite resin device submissions.
Submit Comments
You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))
If unable to submit comments online, please mail written comments to:
Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
All written comments should be identified with this document's docket number: FDA-2024-D-2511.